Genomic newborn screening: ICoNS
Gene: RPS17
Accounts for 1-3% of all DBA.
Penetrance seems high, variable expressivity.
More than 90% of DBA patients present during the first year of life. The diagnosis is generally made at 3 months, of age with a range from birth to adulthood.
Treatment: Corticosteroids and red blood cell transfusions are the mainstays of therapy. Curative treatment - hematopoietic stem cell transplantation
Sources: ClinGen, LiteratureCreated: 21 Apr 2026, 3:11 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Diamond-Blackfan anemia 4
Publications
Variants in this GENE are reported as part of current diagnostic practice
Gene: rps17 has been classified as Green List (High Evidence).
gene: RPS17 was added gene: RPS17 was added to Genomic newborn screening: ICoNS. Sources: ClinGen,Literature Mode of inheritance for gene: RPS17 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: RPS17 were set to 20301769 Phenotypes for gene: RPS17 were set to Diamond-Blackfan anemia 4 Penetrance for gene: RPS17 were set to unknown Review for gene: RPS17 was set to GREEN gene: RPS17 was marked as current diagnostic